Health Condition 1: H350- Background retinopathy and retinalvascular changes
Conditions
Interventions
None listed
Sponsors
Aravind Eye Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with visual acuity better than 6/60 undergoing intravitreal anti VEGF [vascular endothelial growth factor] for following pathologies. 2.Retinal Venous Occlusion Diseases [RVOD]. 3.Diabetic Macular Edema [DME]. 4.Age related Macular Degeneration [AMD]. 5.Polypoidal Choroidal Vasculopathy [PCV].
Exclusion criteria
Exclusion criteria: 1.Patients planned for vitrectomy after anti VEGF[vascular endothelial growth factor]. 2.Neo Vascular Glaucoma [NVG]. 3.Uncontrolled hypertension (>= 160 mm Hg systolic or >= 100 mm Hg diastolic), with or without anti-hypertensive medications. 4.Patients consuming drugs that influence cardiac rate and rhythm (like Beta-blockers). 5.Uncontrolled Diabetes Mellitus (FBS >= 180 mg/dl), despite medications. 6.Patients with dementia, hearing impairment, speech disorder, mental retardation, or patients with any psychiatric ailments, or on any psychiatric medications. 7.Patients with Uveitis. 8.Patients with ocular manifestations of diabetes other than retinopathy-Diabetic neuropathy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) To quantitatively describe the patientsâ?? experiences by determining their opinion [distress level] on the whole injection processTimepoint: 1 year from starting day of study. | — |
Secondary
| Measure | Time frame |
|---|---|
| 2) To assess subjectively (by means of questionnaire) and objectively(by measuring vital signs- pre injection, during injection, post injection) visual experience of patients undergoing intravitreal anti vascular endothelial growth factor.Timepoint: 1 year from starting day of study. | — |
Countries
India
Contacts
Public ContactDr Suresh Mekala
Aravind Eye Hospital
Outcome results
None listed